Ozempic and Wellbutrin (Bupropion) Together: Safety, Weight Loss, and the Mental Health Picture

Direct answer (40-60 words)

Ozempic (semaglutide) and Wellbutrin (bupropion) can be taken together under provider supervision. There's no direct pharmacokinetic interaction, and adding bupropion to a GLP-1 regimen can produce a small additional weight loss benefit. The combination requires monitoring for amplified GI side effects, seizure threshold concerns with bupropion, and routine mental health check-ins.

Table of contents

1. The 30-second answer
2. Why patients take both medications
3. How each drug works, briefly
4. Pharmacokinetic interaction profile
5. Bupropion-specific contraindications worth flagging
6. The added weight loss data with bupropion plus a GLP-1
7. Mental health and GLP-1 medications: what current evidence says
8. Side effect overlap and how to manage it
9. Switching, stopping, and dose adjustments
10. When to call your provider
11. FAQ
12. Footer disclaimers

Why patients take both medications

A meaningful share of patients on weight-loss medication also have a mood condition that's being treated, or vice versa. Bupropion (Wellbutrin) is one of the most commonly prescribed antidepressants in the U.S., partly because its side effect profile (no sexual dysfunction, weight-neutral or weight-loss-favorable) makes it attractive when other antidepressants don't fit.

Ozempic is the most-prescribed GLP-1 receptor agonist in the U.S. for type 2 diabetes, and semaglutide-based therapy (including the higher-dose Wegovy) is also approved for chronic weight management. Many patients land on both, either because their provider added one to address a specific symptom or because they were already on one when the other became indicated.

The pairing is common, and the safety profile is reassuring. The remaining considerations are about monitoring rather than avoidance.

How each drug works, briefly

Ozempic (semaglutide). A GLP-1 receptor agonist that mimics the gut hormone glucagon-like peptide-1. It enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and reduces appetite via central pathways in the hypothalamus. Approved for type 2 diabetes with cardiovascular benefit. Wegovy (the higher-dose semaglutide) is approved for chronic weight management.

Wellbutrin (bupropion). An atypical antidepressant that inhibits the reuptake of norepinephrine and dopamine (NDRI). It does not act on serotonin in the way SSRIs do. Approved for major depressive disorder, seasonal affective disorder, and (as Zyban) smoking cessation. Used off-label for adult ADHD and as a component of Contrave (bupropion plus naltrexone) for chronic weight management.

The two drugs act on completely different targets, in different organ systems, with non-overlapping metabolism. That's the basic reason there's no pharmacokinetic interaction.

Pharmacokinetic interaction profile

Bupropion is metabolized primarily by CYP2B6 in the liver. Semaglutide isn't metabolized through CYP enzymes at all. It's broken down by ubiquitous proteolytic enzymes in the bloodstream and excreted via urine and feces.

Because the two drugs use entirely separate elimination pathways, neither raises or lowers blood levels of the other. Drug interaction databases (Lexicomp, Micromedex, Stockley's) list no clinically significant pharmacokinetic interaction between semaglutide and bupropion.

What can happen is a pharmacodynamic overlap, where two drugs hit the same physiological system from different angles. Both Ozempic and bupropion can cause nausea. Both can occasionally cause appetite suppression. Both have central nervous system effects (Ozempic via the gut-brain axis, bupropion directly on neurotransmitters). When effects stack, patients sometimes feel them additively.

The seizure threshold is the more important pharmacodynamic question, but it's mostly about bupropion alone, which lowers the seizure threshold modestly. Ozempic doesn't independently affect seizure risk. The combination doesn't multiply the bupropion seizure signal.

Bupropion-specific contraindications worth flagging

Bupropion has its own list of absolute contraindications that exist independent of any GLP-1 medication. Patients adding Wellbutrin to an Ozempic regimen should know these:

• Active seizure disorder. Bupropion lowers the seizure threshold and is contraindicated in epilepsy or any condition with elevated seizure risk.
• Active or recent eating disorder (anorexia or bulimia). Eating disorders carry electrolyte disturbances that further raise seizure risk on bupropion. Combined with Ozempic-induced reduced food intake, the picture gets riskier.
• Abrupt discontinuation of alcohol or sedatives (benzodiazepines). Withdrawal seizures are more common, and bupropion compounds risk.
• MAO inhibitor use within 14 days. Hypertensive crisis risk.
• Known hypersensitivity to bupropion.

The eating disorder contraindication is the one that comes up most often in weight-loss settings. Patients with a remote history of bulimia nervosa who are now stable can sometimes still take bupropion under specialist care, but this is a clinical judgment, not a default.

Patients on Ozempic for weight loss who are losing rapidly (more than 2 percent of body weight per week) should mention this when starting bupropion. Rapid weight loss can transiently disturb electrolytes and theoretically affect seizure threshold.

The added weight loss data with bupropion plus a GLP-1

This is the part of the question patients are usually most interested in: does adding Wellbutrin help me lose more weight on Ozempic?

The published data is suggestive but not enormous.

Bupropion alone for weight loss. In a randomized trial of bupropion 300-400 mg daily for chronic weight management (Anderson et al., Obesity Research, 2002), patients lost roughly 4 to 5 percent of body weight over 48 weeks. Modest, but real.

Bupropion plus naltrexone (Contrave). The combination is FDA-approved for chronic weight management. In the COR-I and COR-II trials, patients on Contrave lost about 5 to 6 percent of body weight at one year, vs 1 to 2 percent on placebo.

Adding Contrave to a GLP-1. A small open-label study (Hollander et al., 2022) of patients on liraglutide who added bupropion-naltrexone showed an additional 4 percent body weight reduction over 6 months compared to liraglutide alone.

Semaglutide plus bupropion specifically. No published randomized trial yet. The mechanism overlap between GLP-1 appetite suppression (gut-brain pathway via vagal afferents and hypothalamic POMC neurons) and bupropion-naltrexone appetite suppression (central reward pathway via NDRI plus opioid receptor antagonism) is complementary, not redundant. Real-world clinical observation is that the additive effect is small but real (1 to 4 percent additional weight loss).

For most patients, the weight loss benefit of adding bupropion to Ozempic is incremental, not meaningful. The stronger reason to be on both is mood treatment plus weight management, with the weight loss synergy as a small bonus.

For a deeper look at antidepressants and GLP-1 weight loss, see our related guidance on SSRIs and Ozempic.

Mental health and GLP-1 medications: what current evidence says

Around 2023, concerns surfaced about a possible link between semaglutide and suicidal ideation. The FDA and EMA both opened reviews, and both eventually concluded that the evidence does not support a causal link between GLP-1 receptor agonists and increased suicide risk.

A large pharmacovigilance study (Wang et al., JAMA Internal Medicine, 2024) of more than 240,000 patients on semaglutide found no elevated rate of suicidal ideation compared to non-GLP-1 weight loss medications. A subsequent meta-analysis (NIH-funded, 2024) reached the same conclusion.

That said, mood changes during weight loss are common regardless of the medication. Reasons range from the social complexity of body changes, to relationship dynamics, to underlying depression that was being masked by food-based coping. Patients on bupropion plus Ozempic should keep their mood follow-up appointments and not dismiss new mood symptoms as "just the medication."

If a patient on stable bupropion suddenly feels the antidepressant is "not working as well" after starting Ozempic, the more likely explanations are: weight loss disrupting routines and sleep, dietary changes affecting absorption (rare with bupropion), or the natural waxing of mood symptoms unrelated to the GLP-1 itself. Don't change bupropion dose unilaterally.

Side effect overlap and how to manage it

Both medications can cause nausea, dry mouth, headache, and insomnia. The combination doesn't usually amplify these in a problematic way, but a few patterns are worth knowing.

Nausea. Ozempic-induced nausea is most pronounced in the first 24 to 72 hours after the weekly injection and during titration. Bupropion-induced nausea, when it occurs, tends to happen with the first 1 to 2 weeks of starting or after dose increases. If you start both around the same time, expect a rougher first month. Stagger starts when possible: get stable on one before adding the other.

Insomnia. Bupropion can cause insomnia, especially at higher doses (300+ mg daily) or with afternoon dosing. If you're losing sleep on Wellbutrin XL, take it as early in the morning as possible. Ozempic doesn't typically cause insomnia directly, but rapid weight loss can disrupt sleep architecture independently.

Dry mouth. Both drugs can dry the mouth. Sugarless gum, frequent water sips, and avoiding caffeine help. Severe persistent dry mouth on the combination warrants a provider conversation, since it can affect dental health.

Headache. Mild headache is common with both. Persistent severe headache, especially if accompanied by visual changes or unusually high blood pressure, is not normal and needs evaluation.

Constipation. Ozempic slows GI motility. Bupropion is fairly neutral on motility. Constipation on the combination is an Ozempic effect more than a bupropion effect. Standard management applies: fiber, water, magnesium, or stool softeners as needed.

Switching, stopping, and dose adjustments

A few practical scenarios:

You're already on Wellbutrin and your provider wants to start Ozempic. Standard Ozempic titration applies. Don't change your bupropion dose. Plan for amplified GI side effects in the first 4 to 6 weeks, but they should settle.

You're already on Ozempic and your provider wants to start Wellbutrin. Standard bupropion titration applies (typically 150 mg daily for 3 to 7 days, then increasing to 300 mg daily). The first week is when seizure threshold matters most. If you've been losing weight rapidly on Ozempic, mention that to the prescriber.

You want to stop one of them. Don't stop bupropion abruptly without provider guidance. Withdrawal-like symptoms (worsening mood, irritability, sleep disturbance) can occur. Most providers taper bupropion over 1 to 2 weeks. Ozempic doesn't have a withdrawal syndrome, but stopping it can cause weight regain. Both decisions should involve the prescriber.

You want to switch to Contrave (bupropion plus naltrexone). This is a different conversation. Contrave can't be combined with another bupropion-containing medication, so you'd taper Wellbutrin first. Whether to add Contrave on top of Ozempic is a clinical decision that involves looking at total daily bupropion equivalents and the weight loss target.

When to call your provider

Within 24 hours:

• New mood symptoms (worsening depression, hopelessness, suicidal thoughts)
• Persistent severe headache
• Significant insomnia (less than 4 hours of sleep for 3+ nights)
• Severe nausea or vomiting that interferes with hydration or eating
• Glucose readings below 70 mg/dL repeatedly (if also on diabetes medication)

Same-day or emergency care:

• Any seizure or seizure-like event
• Allergic reaction (hives, facial swelling, throat tightness)
• Severe abdominal pain (especially upper-quadrant, radiating to the back)
• Signs of severe dehydration (confusion, dizziness, no urine for 12+ hours)
• Active suicidal ideation with intent or plan

The seizure point is worth re-emphasizing. Bupropion-related seizures are rare (less than 0.1 percent at standard doses) but real. They tend to happen in the first weeks of treatment or after dose increases. Any seizure-like episode warrants immediate medical evaluation.

FAQ

Is it safe to take Ozempic and Wellbutrin together?

Yes, generally. There's no direct drug interaction. The combination is monitored for shared side effects (nausea, dry mouth, insomnia) and bupropion-specific concerns (seizure threshold, eating disorder history).

Will I lose more weight on Ozempic if I add Wellbutrin?

Possibly, by a small margin. Real-world observation suggests an additional 1 to 4 percent body weight reduction over 6 months when bupropion is added to a GLP-1. The effect is incremental, not dramatic.

Can Wellbutrin cancel out my Ozempic?

No. Bupropion does not interact with semaglutide in a way that reduces its effectiveness. Older concerns about antidepressants reducing GLP-1 weight loss were specific to certain SSRIs at lower GLP-1 doses, not to bupropion.

Should I stop Wellbutrin before starting Ozempic?

No. There's no reason to stop a working antidepressant before adding Ozempic. Standard semaglutide titration applies whether or not you're on bupropion.

What about Contrave (bupropion plus naltrexone) with Ozempic?

This combination is sometimes used clinically, but it requires careful provider oversight. You can't combine Contrave with separate Wellbutrin (you'd be double-dosing bupropion). The added naltrexone has its own side effect profile.

Does Ozempic affect mood?

The published evidence does not show a causal link between semaglutide and worsened mood or suicidal ideation. Mood changes during weight loss are common from non-medication factors. New mood symptoms still warrant a provider conversation.

Can I take Wellbutrin and compounded semaglutide?

Yes. Compounded semaglutide acts through the same pharmacology as Ozempic and has the same interaction profile with bupropion. The compounded vs brand decision is independent of antidepressant choice.

Will Wellbutrin cause a seizure on Ozempic?

The seizure risk is bupropion-related, not Ozempic-related. The combination doesn't increase seizure risk beyond what bupropion alone does (less than 0.1 percent at recommended doses). Risk factors for seizure (eating disorders, alcohol withdrawal, head injury) matter more than the GLP-1.

Will my Wellbutrin dose need to change on Ozempic?

Usually no. Bupropion dosing is based on indication and response, not on body weight. Significant weight loss (more than 15 percent of starting weight) can affect drug distribution for some medications, but bupropion's dosing is not weight-adjusted.

What if I miss a Wellbutrin dose while on Ozempic?

Take it as soon as you remember, unless it's near the next scheduled dose. Don't double up. Missing doses occasionally is fine; chronic missed doses can lead to mood symptoms.

Are there alternatives if Wellbutrin and Ozempic together cause too many side effects?

Yes. Alternative antidepressants (SSRIs, SNRIs) and alternative weight management approaches exist. The decision depends on which medication is most clearly helping and what's driving the side effects.

Can I drink alcohol on Wellbutrin and Ozempic?

Bupropion plus alcohol increases seizure risk and can amplify mood instability. Ozempic plus alcohol increases nausea and hypoglycemia risk. Combine all three and the picture is unfavorable. Most providers recommend minimizing alcohol on the combination.

Author / review note

Reviewed by the FormBlends Medical Team. References include the Wellbutrin XL prescribing information (GlaxoSmithKline, 2023), Wang et al., JAMA Internal Medicine, 2024 (semaglutide and suicidal ideation), and Hollander et al., 2022 (bupropion-naltrexone added to liraglutide).

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic and Wegovy are registered trademarks of Novo Nordisk. Wellbutrin and Zyban are registered trademarks of GlaxoSmithKline. Contrave is a registered trademark of Currax Pharmaceuticals. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.